Trattamento Profilattico Con Mitomycin-C Dei Tumori Uroteliali Superficiali Della Vescica

Alfthan O. , Janhiainen : Instillation prophylaxis of superficial bladder cancer with Mitomycin-C vs. Doxorubicin. Abst. European Association of Urology, 7^th Congr., Budapest, June 26–28, 1986.

Barnes R. : Changes in grade and stage of recurrent bladder tumors, J. Urol., 118; 177 (1977).

Binsack T. , Williams W. : Carcinoma associated hemolytic-uremia syndrome in a patient receiving 5-Fluorouracil-Adriamycin-Mitomycin-C combination chemotherapy. Oncology, 45; 11–14 (1988).

Bono A.V. , Pozzi E. , De Francesco O. : Intravesical chemoprophylaxis in superficial bladder cancer. A controllated study. Abst. European Association of Urology, 7^th Congr., Budapest, June 26–28, 1986.

Devonec M. , Bouvier R. , Sarkissian J. , Bendiremand O. , Gelet A. , Dubernard J.M. : Intravesical instillation of Mitomycin-C in the prophylactic treatment of recurring superficial transitional cell carcinoma of the bladder. Brit. J. Urol., 55; 382–385 (1983).

Fluchter S.H. , Bichler K.H. , Harzman R. , Erdman D. : Local Mitomycin-C therapy of transitional cell carcinoma of the bladder. Serum resorption study and clinical results. In: Mitomycin-C, Current Impact on Cancer Therapy, Ogawa M. , Rosencweig M. Staquet M.J. (eds.), 143–152. Excerpta Medica, Amsterdam.

Gilbert H.A. , Logan J.L. , Kolan A.R. : The natural history-of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histological grading. J. Urol., 119; 488–492 (1978).

Grossman H.B. : Current therapy of bladder carcinoma. J. Urol., 121; 1 (1979).

Heney N.M. , Nocks B.N. , Daly J.J. , Prout G.R. , Newall J.B. , Griffen T.P. , Perrins T.L. , Szyfelbein W.A. : T₂ and T₁ bladder cancer: location, recurrence and progression. Brit. J. Urol., 54; 152–157 (1982).

Huland H. , Otto U. : Mitomycin instillation to prevent recurrence of superficial bladder carcinoma, results of a controllated prospective study in 58 patients. Eur. Urol., 9; 84 (1983).

Huland H. , Otto U. , Droese M. , Kloppel G. : Long term mitomycin-C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival. J. Urol., 132; 27 (1984).

Huland H. , Otto U. : Use of Mitomycin-C as prophylaxis following endoscopic resection of superficial bladder cancer. Urology, 26; 32–35 (1985).

Libera M. , Tenaglia R. , De Bernardis E. , Gentile V. : Neoplasie primitive della vescica alio stadio Pi. Valutazione critica dei risultati ottenuti con l'impiego dell'Adriamicina e della Mitomycina-C nella profilassi delle recidive. Minerva med., 75; 391–394 (1984).

Liberti M. , De Bernardis E. , Gentile V. , Perugia G. : Role of Mitomycin-C in the prophylaxis of recurrences in superficial bladder cancer. Abst. European Association of Urology, 7^th Congr. Budapest, June 26–28, 1986.

Lutzeyer W. , Rubben H. , Dahm H. : Prognostic parameters in superficial bladder cancer: analysis of 315 cases. J. Urol, 127; 250–252 (1982).

McFarlane J.R. , Tolley D.A. , Scottish Urological Oncology Group: Intravesical Mitomycin-C therapy for superficial bladder cancer. Report of a multicentre phase II study. Brit. J. Urol., 57; 37–39 (1985).

Mishina T. , Ode K. , Murata S. , Ooe H. , Mori Y. , Takahashi T. : Mitomycin-C bladder instillation therapy for bladder tumors. J. Urol., 114; 217–219 (1975).

Mishina : Prophylactic use of Mitomycin-C bladder instillation for preventing the recurrence of bladder tumors. Abst. Proc. 19^th Intern. Congr. Soc. Intern. d'Urol., S. Francisco, September 5–10, 1982.

Mishina T. , Maegawa M. , Watanabe H. , Nakao M. , Kobayashi T. , Nakagawa S. : Absorption of anticancer drugs though bladder epithelium. Urology, 26 (1985).

Narayama A.S. : Bladder cancer: factors affecting survival. J. Urol., 130; 56 (1983).

Nissenkorn I. , Herrod H. , Soloway M.S. : Side effects associated with intravesical Mitomycin-C. J. Urol., 126; 596–597 (1981).

O'Flynn J.D. , Smith J.M. , Hanson J.S. : Transurethral resection for the assessment and treatment of vesical neoplasms: a review of 840 consecutive cases. Eur. Urol., 1; 38 (1975).

Pockock R.D. , Pouder B.A.J. , O'Sullivan J.P. , Ibrahim S.K. , Easton D.F. , Skewer R.J. : Prognostic factors in non-infiltrating carcinoma of the bladder: a preliminary report. Brit. J. Urol., 54; 711–715 (1982).

Soloway M.S. , Ford K.S. : Subsequent tumor analysis of 36 patients who have received intravesical Mitomycin-C for superficial bladder cancer. J. Urol., 130; 74–78 (1983).

Van der Meijden A.P.M. , De Bruyne F.M.J. : Treatment schedule of intravesical chemotherapy with Mitomycin-C in superficial bladder cancer: Short-term courses or maintenance therapy. Urology, 31; Suppl., 26–29 (1988).

Wajsman Z. , McGill W. , Englander L. , Huber R.P. , Pontes J.E. : Severely contracted bladder following intravesical Mitomycin-C therapy. J. Urol., 130; 340–341 (1983).